Department of Radiation Oncology

Technical evaluation of the cone-beam computed tomography imaging performance of a novel, mobile, gantry-based X-ray system for brachytherapy (2021) Karius A, Karolczak M, Strnad V, Bert C Journal article Definitive chemoradiotherapy of locally advanced head and neck cancer in combination with immune checkpoint inhibition-new concepts required (2021) Hecht M, Fietkau R, Gaipl U Journal article, Editorial A Comparison of Single- and Multiparametric MRI Models for Differentiation of Recurrent Glioblastoma from Treatment-Related Change (2021) Eisenhut F, Engelhorn T, Arinrad S, Brandner S, Coras R, Putz F, Fietkau R, et al. Journal article Identification of an endogenous retroviral signature to predict PD-1 blockade response in advanced clear cell renal cell carcinoma: Integrated analysis of three clinical trials (2021) Zhou JG, Wang H, Ma H, Gaipl U Conference contribution An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma (2021) Kehl N, Schlichtig K, Dürr P, Bellut L, Dörje F, Fietkau R, Pavel ME, et al. Journal article Die Bedeutung der Strahlentherapie im Kontext immer effektiver werdender Systemtherapien beim metastasierten NSCLC – Hinweise aus einer Rezidivanalyse nach Immuncheckpointinhibitoren (2021) Schubert P, Fietkau R, Hecht M Journal article Correction to: Innovative radiation oncology Together—Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany (Strahlentherapie und Onkologie, (2021), 197, 12, (1043-1048), 10.1007/s00066-021-01843-9) (2021) Krug D, Hecht M, Ebert N, Maurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article, Erratum Letter comments on: The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy (2021) Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V Journal article Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites? (2021) Weissmann T, Höfler D, Hecht M, Semrau S, Haderlein M, Filimonova I, Frey B, et al. Journal article Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article